NovoCure
NVCR
NVCR
238 hedge funds and large institutions have $2.73B invested in NovoCure in 2024 Q4 according to their latest regulatory filings, with 54 funds opening new positions, 65 increasing their positions, 78 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
7% more funds holding
Funds holding: 223 → 238 (+15)
1.18% less ownership
Funds ownership: 85.82% → 84.63% (-1.2%)
17% less repeat investments, than reductions
Existing positions increased: 65 | Existing positions reduced: 78
Holders
238
Holding in Top 10
5
Calls
$68.8M
Puts
$17.7M
Top Buyers
| 1 | +$81.6M | |
| 2 | +$28.3M | |
| 3 | +$20.5M | |
| 4 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
+$16.3M |
| 5 |
Capital World Investors
Los Angeles,
California
|
+$15.1M |
Top Sellers
| 1 | -$81M | |
| 2 | -$33.2M | |
| 3 | -$19M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$15.2M |
| 5 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
-$14.8M |